Pacira Hits Rivals With False Ad Suits Over Pain Drugs
Pharmaceutical company Pacira BioSciences Inc. is looking to stop rivals from marketing their so-called generic versions of its non-opioid based drug used to manage post-surgery pain, claiming in three separate lawsuits...To view the full article, register now.
Already a subscriber? Click here to view full article